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Background/aim: To compare estrogen and betamethasone in the topical treatment of labial adhesions in prepubertal girls.
Materials and methods: In this retrospective study, we evaluated 39 girls with labial adhesions covering at least 50% of the vaginal
opening. Of the total patients, 20 were treated with a topical estrogen preparation, while the remaining 19 patients were treated with a
combination of betamethasone cream and petroleum ointment (Vaseline) for 3 to 9 weeks.
Results: Sixteen of 20 (80%) patients in the estrogen treatment group were treated successfully with topical estrogen cream only, and
17 of 19 (89.4%) patients in the second group were treated successfully with a combination of betamethasone cream and petroleum
ointment. Two patients (2/20) in the estrogen treatment group underwent a surgical procedure for the manual separation of the labial
adhesion. One patient (1/19) treated with betamethasone cream and petroleum ointment required a manual separation procedure.
We observed a side effect of labial enlargement in 2 patients (10%) who were treated with estrogen only, while the only side effect
of the betamethasone treatment was local irritation, which occurred in a single patient (5.2%). In addition, the success rate of the
betamethasone treatment exceeded that of the topical estrogen (89.4% and 80%, respectively).
Conclusion: Betamethasone cream with petroleum ointment is a safe and effective primary therapy for prepubertal labial adhesions.
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1. Introduction
Labial adhesion is the partial or complete adherence of
the labia minora (1) originating at the posterior fourchette
and extending towards the clitoris (2). Labial adhesions
occur in 1.8% of females, with a peak incidence at 13 to 23
months of age. However, the prevalence of labial adhesions
may be greater due to the low rate of detection among
asymptomatic children (3). Although often asymptomatic,
labial adhesions may become apparent when they result
in postvoid dripping (urinary incontinence), urinary
tract infections, vaginitis (vaginal irritation), hematuria,
and increased urinary frequency (4). Labial adhesion
may occur as a result of inflammation or low prepubertal
estrogen levels (4).
Therefore, topical estrogen therapy is the treatment of
choice (1). Estrogen creams, however, may have unwanted
side effects, such as breast budding, labial engorgement, and
hyperpigmentation (5). While topical estrogen creams have
potentially significant side effects, topical steroid creams,
such as 0.05% betamethasone, are very well tolerated with
no significant side effects for the majority of cases and only
* Correspondence: erturknazile@gmail.com

local irritation occurring in some individuals (5). In this
retrospective study, we have evaluated the effectiveness of
estrogen and 0.05% betamethasone cream, applied twice
daily, in the treatment of prepubertal labial adhesions.
2. Materials and methods
Children of all ages are referred to our gynecology training
and research hospital with gynecological problems. Thus,
a wide age range of children (2 months to 9 years) were
included in this study. Study inclusion criteria were fusion
of at least 50% of the vaginal opening, absence of significant
clinical symptoms (urinary infection, painful or altered
urinary stream, recurrent vulvar or vaginal infections,
postvoid dripping, etc.), and prior medical history of labial
fusion treatment of any kind. The study group included
39 girls diagnosed with labial adhesion in our ambulatory
care clinic who underwent topical treatment between
February 2010 and July 2012.
The patients were divided into 2 groups according
to the method of treatment without any randomization.
Patients attending the clinic during the first 1.5 years of
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the study period (n = 20) constituted the first group (G1),
while patients diagnosed during the last year (n = 19)
composed the second group (G2). We prescribed 3 weeks
of topical estrogen cream to G1 patients and a combination
of topical corticosteroids (0.05% betamethasone cream)
and petroleum ointment (Vaseline) to G2 patients. Several
recent publications have suggested that corticosteroids
are effective in the treatment of labial adhesion (4,5).
Subsequently, our treatment protocol was revised to
include betamethasone treatment in the last year.
The parents of the children were instructed to apply
a thin layer of estrogen or betamethasone cream to the
raphe along the adhesion line twice daily. A single course
of treatment was defined as a 3-week course. All children
were treated with 1 to 3 courses. Outcomes were stratified
into several categories: successful, partially successful, and
requiring surgical therapy. The successful category was
defined as complete separation of the labia. Treatment
resulting in greater than 75% separation of labia was
considered a partial success. Patients whose lesions did not
respond to topical therapy or whose parents chose surgical
therapy after first undergoing topical therapy were placed
into the surgical category.
A review of patient medical history, current medical
charts, parent interviews, and office examinations were
all included in the analysis of clinical characteristics. The
data collected included the duration of the topical estrogen
treatment or of the topical betamethasone treatment,
side effects of medical therapy, incidence of successful
separation, incidence of recurrence, percentage requiring
surgery, and any perceived advantages of the 2 treatments.
Due to the small sample size, the Fisher exact test
was used to determine the statistical significance of any
differences between the treatment groups. P = 0.05 was
established as the threshold of statistical significance.

3. Results
The 39 patients included in the study ranged in age from 2
months to 9 years old. The first group included 20 patients
and had a mean age of 2.8 years (ranging from 3 months to
9 years); the second group included 19 patients and had a
mean age of 2.4 years (ranging from 2 months to 8 years).
When the groups were compared for age, there was no
difference between them (P = 0.508). The treatment and
outcome of the study groups are depicted in Figure 1.
The 20 patients of the G1 group were prescribed 3 weeks
of topical estrogen treatment; of those in G1, 13(65%)
experienced complete resolution of labial fusion within
3 weeks. Following the first treatment course, continued
treatment was recommended to 7 (35%) patients for
whom the initial treatment had failed. Despite continued
treatment efforts, the parents of 2 patients (2/7) indicated
that the topical treatment had not resolved their concerns
and expressed a desire to further correct the condition. The
parents of these patients consented to surgical resolution
of labial adhesion. Fused labia were opened surgically
under local anesthetic (lidocaine gel). A total of 3 patients
out of the original 7 undergoing extended treatment used
topical estrogen for a total of 6 weeks. Labial adhesion
was completely resolved in these children and did not
reoccur during follow-up. Two children in the same
group (2/7) showed no improvement in symptoms, with
1 experiencing a partial opening of the labial adhesion
and 1 being completely unaffected by the treatment. A
third course of treatment was initiated in these patients;
however, no separation occurred. Surgical treatment of
labial adhesion was conducted in these patients under
local anesthesia.
The 19 children included in G2 were treated with
betamethasone cream and petroleum ointment (Vaseline,
Unilever) in succession, twice daily over a period of 3
weeks. These patients were advised to continue the use of

Total 39
patients

G1- 20 patients
estrogen

After 1 course
7 patients

After 1 course
13 successes

No
recurrence

G2- 19 patients
betamethasone

2 patients
request manual
separation

After 2nd
course
3 successes

After 1 course
14 successes

After 2nd course
2 patients no
separation

After 3rd course
no separation , surgical
treatment conducted

Figure 1. A schematic description of the study groups.
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After 2nd course
3 patients no
separation
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petroleum ointment for 1 month after labial separation.
The protocol was applied to 19 children (G2), of whom
14 (73.6%) experienced complete resolution of labial
adhesion within 3 weeks. However, symptoms did not
completely resolve in 5 patients. One of these patients
opted for surgical treatment prior to completion of the
betamethasone course due to difficulties with treatment
compliance. Surgical opening of the labial adhesion
was performed under local anesthesia. The remaining
4 children (4/5) did not express excessive discomfort
with the treatment, which was subsequently continued
for 3 weeks. During the second course of treatment,
labial adhesion resolved completely in 1 of the children
but continued in the remaining patients. A third course
of treatment was initiated. During this period (9 weeks)
labial adhesion resolved completely in 2 patients, and,
in 1 patient, symptoms continued and local irritation
developed. Betamethasone treatment was then terminated
and manual separation of labial adhesion was conducted.
There was no recurrence during the follow-up period
in these patients.
4. Discussion
Labial adhesion, also known as labial agglutination, is
a thin membranous adhesion of varying length of the
labia minora (2). The adhesion originates at the posterior
fourchette and extends towards the clitoris (2). The
etiology of labial adhesion is unknown but is presumed
to be related to hypoestrogenism and vulvar irritation
in prepubertal girls (6). The majority of cases of labial
adhesion are asymptomatic and resolve spontaneously
once endogenous and exogenous estrogen increase at
puberty (5). Prepubertal labial adhesions occur in 0.6%–
3.0% of girls (5). Although most patients are asymptomatic,
labial adhesion is often diagnosed when adhesions become
inflamed or begin to interfere with voiding. Dysuria and
recurrent vulvar or vaginal infections are typical symptoms
at initial presentation. On rare occasions, urinary
retention may occur when complete adhesion is present
(3). Low estrogen expression is the most widely accepted
cause of labial adhesion, and supplementation with
topical estrogen treatment is the mainstay of therapy (6).
Historically, medical treatment of labial adhesion involved
a regimen of topical estrogen applied for an unspecified
period of time, with the physician monitoring the response
to treatment and the continued presence of adhesion (4).
This method of treatment is successful in approximately
50%–88% of patients, and it typically results in separation
of the adhesion within 2–8 weeks (3,4). Topical estrogen
creams are often well tolerated; however, side effects such
as hyperpigmentation of the labia and premature breast
development have been reported. Serious side effects
such as vaginal bleeding and precocious puberty are

possible (5,6). Two (10%) of our 20 patients who had been
previously treated with estrogen cream (G1) experienced
labial engorgement during the treatment that resolved
once the treatment was terminated.
Topical estrogen has known side effects, while topical
steroids are well tolerated. Elmore et al. (7) and Chu et
al. (8) used betamethasone cream successfully in the
treatment of phimosis in children, reporting no significant
side effects.
In accordance with recent studies, betamethasone
cream in conjunction with topical estrogen therapy has
been promoted as a novel treatment modality (4,5,9).
The reported success rate of topical estrogen cream varies
between 47% and 100%, depending on treatment frequency
and length (1,3,10). Myers et al. (5) reported a success rate
of 81% following treatment with betamethasone cream.
Mayoglou et al. (4) reported treatment durations of 2.2
months and 1.25 months, respectively. In our study, the
duration of the betamethasone treatment was shorter,
approximately half the treatment duration of that reported
by Leung et al. (1) (2.4 months). The success rates for topical
estrogen and betamethasone in the present study were
80% and 89.4%, respectively (Figure 2), with treatment
durations of 4 weeks and 3.1 weeks, respectively. This is
in agreement with some published reports. Sanfilippo
(11) reported that 1 week of treatment was effective in
more than 90% of cases. Opipari (12) recommended
treatment with topical estrogen for 4 to 12 weeks. Aribarg
(13) reported that, out of 25 girls with severe adhesion of
the labia minora, 22 (88%) of the patients were treated
successfully by topical estrogen within 1 month.
Some physicians recommend surgical separation if the
labia remain fused following 2 weeks of topical therapy
(3,14). Muram (3) performed a retrospective chart review
of 259 girls with symptomatic labial adhesion. These
patients were treated with topical estrogen for 10 to 14
days, with labial adhesion resolving in 121 (47%) patients.
Surgical separation of labial adhesion was conducted
under local anesthesia in 138 girls who did not respond
to topical therapy. In our study, 2 patients from the first
Sucresssate %
89.4

80

Figure 2. Success rates of estrogen (blue bar) and betamethasone
(red bar) treatment in patients with labial adhesions.

1105

ERTÜRK / Turk J Med Sci
group and 1 patient from the second group underwent
surgical treatment due to parental concerns after the first
course of topical therapy proved unsuccessful.
No clinical guidelines regarding the duration of topical
therapy have been determined (4). The potential risks of
long-term topical estrogen or betamethasone treatment,
including adrenal suppression and cancer, remain
unknown (4). In the current study, 2 patients from G1
and 1 patient from G2 did not respond to treatment after
3 courses of topical therapy and, therefore, underwent
surgical separation. For unresponsive or refractory cases,
manual separation with local anesthetic gel is the treatment
of choice. While topical estrogen creams have potentially
significant side effects, topical steroid creams such as
0.05% betamethasone are well tolerated with no significant
side effects other than local irritation. In our study, labial
swelling was observed in 2 (10%) patients during the use
of topical estrogen. In the topical betamethasone treatment
group, 1 (5.2%) patient developed local irritation. It can
thus be concluded that betamethasone has fewer side
effects relative to topical estrogen.
Although the difference was not statistically significant
(P = 0.356), we observed a trend indicating that
betamethasone may be more effective than estrogen due to
reduced treatment time, a higher rate of treatment success,
and fewer side effects. While our study was retrospective and
included a limited number of participants, our experience
suggests that treatment with 0.05% betamethasone cream
applied twice daily is safe and has an effectiveness that is
comparable to estrogen cream therapy in the treatment of
prepubertal labial adhesions.
Follow-up examinations at 3 and 9 months revealed
no recurrence of adhesions in the first treatment group.
None of the patients needed another treatment course in
the second treatment group over a mean follow-up period
of 1.5 years. Other studies have reported no recurrence
following successful treatment of labial adhesion (1). The
absence of recurrence may be related to our emphasis
on the importance of meticulous introital hygiene to
minimize inflammation and to the application of a
petroleum ointment (Vaseline) for 1 month following
the treatment course in order to minimize readhesion. In
this study we used betamethasone cream with petroleum

ointment to reduce the incidence of local irritation caused
by betamethasone cream. We recommend the use of
betamethasone cream with petroleum ointment.
We advise the parents of children treated for labial
adhesion to follow up in the event of any recurrence and
to continue the use of petroleum ointment to prevent
adhesions. In the case of continued adhesions or severe
cases, we advise the patients and their families to report to
the hospital. This approach promotes careful treatment and
follow up in the home environment. Treatment decisions
concern both parents and children, and physicians should
provide accurate information and support to all involved.
In our study, there were children or families in both
treatment groups who refused topical treatment. Many
girls with labial adhesion were admitted with a presumptive
diagnosis of absent vagina, commonly a result of parental
anxiety. When parental anxiety is extreme, we suggest
manual separation instead of topical treatment. In such
cases, parental attitudes complicate long-term treatment
with topical medications.
In conclusion, both topical estrogen and betamethasone
are effective treatments for labial adhesion in the majority
of patients. Our findings support previously published
data indicating that labial adhesions respond well to
topical betamethasone therapy. Betamethasone cream
(0.05%) is a safe and effective treatment for prepubertal
labial adhesions with a favorable side effect profile relative
to topical estrogen. Further interventions may be required
in patients with labial adhesions that do not respond to
topical therapy.
•

•
•
•

Clinical summary:
Topical treatment with betamethasone cream is
effective in the majority of patients and can be used
safely to treat symptomatic prepubertal girls with labial
adhesions.
Successful and complete treatment of labial adhesion
with topical preparations may take several weeks.
The use of petroleum ointment with betamethasone
reduces the potential side effects of betamethasone
We advise the parents to continue to use petroleum
ointment for 1 month after the resolution of labial
adhesion.
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